{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:29:37Z","timestamp":1793104177242,"version":"4.5.0"},"reference-count":24,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T00:00:00Z","timestamp":1635120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100002301","name":"Eesti Teadusagentuur","doi-asserted-by":"publisher","award":["PRG722"],"award-info":[{"award-number":["PRG722"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Estonian Ministry of Social Affairs"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Med Screen"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Organised cervical cancer screening was started in Estonia in 2006, but participation is still low. Human papillomavirus (HPV) self-sampling has proved to increase screening uptake. This study addressed the feasibility of HPV self-sampling and the acceptance of this method among long-term screening non-attenders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A randomised intervention study was conducted in Estonia in 2020. Women born in 1958\u20131983 without a Pap smear in 2013\u20132019 were identified in the Estonian Health Insurance Fund database. From them, 12,000 women were randomly allocated to three equal-sized study groups. The opt-out group received a questionnaire and a Qvintip\u00ae sampling device by regular mail. Two opt-in groups received a questionnaire and an e-mail invitation to order a self-sampler online; one received Qvintip and the other Evalyn\u00ae Brush. Participant\u015b background characteristics were obtained from the Population Register. The effect of covariates on participation rate was estimated with multivariate Poisson regression. Acceptance of self-sampling was analysed according to agreement with statements in the questionnaire.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The overall participation rate was 16% with significant differences between opt-out (26%) and opt-in (11%) groups. Compared to the opt-out Qvintip group, adjusted relative risks for the Qvintip and Evalyn Brush opt-in groups were 0.41 (95% confidence interval (CI) 0.37\u20130.45) and 0.44 (95% CI 0.40\u20130.49), respectively. Participation was associated with living place, citizenship, and education. Self-sampling was well accepted: 98% agreed that it was easy to use, 88% preferred it as a screening method in future.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The results show the feasibility and good acceptance of HPV self-sampling among long-term screening non-attenders in Estonia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/09691413211052499","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T11:16:40Z","timestamp":1635160600000},"page":"53-60","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":17,"title":["Human papillomavirus self-sampling for long-term non-attenders in cervical cancer screening: A randomised feasibility study in Estonia"],"prefix":"10.1177","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4769-0008","authenticated-orcid":false,"given":"Piret","family":"Veerus","sequence":"first","affiliation":[{"name":"Department of Epidemiology and Biostatistics, National Institute for Health Development, Tallinn, Estonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reeli","family":"Hallik","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, National Institute for Health Development, Tallinn, Estonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaak","family":"J\u00e4nes","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, National Institute for Health Development, Tallinn, Estonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"J\u00f5ers","sequence":"additional","affiliation":[{"name":"Tartu University Hospital United Laboratories, Tartu, Estonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiu","family":"Paapsi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, National Institute for Health Development, Tallinn, Estonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaia","family":"Laidra","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, National Institute for Health Development, Tallinn, Estonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaire","family":"Innos","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, National Institute for Health Development, Tallinn, Estonia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,10,25]]},"reference":[{"key":"bibr1-09691413211052499","unstructured":"Estonian Health Insurance Fund. Available at: https:\/\/haigekassa.ee\/en. (Accessed October 13, 2021)."},{"key":"bibr2-09691413211052499","unstructured":"Cervical cancer screening factsheet Estonia, 2017. Nordscreen database. Available at: https:\/\/nordscreen.org\/wp-content\/uploads\/2017\/07\/cervix-fact-sheet-estonia-2017.pdf. (Accessed July 1,2021)."},{"key":"bibr3-09691413211052499","unstructured":"Cancer Incidence in Five Continents. Available at: https:\/\/gco.iarc.fr\/databases.php. (Accessed February 14, 2021)."},{"key":"bibr4-09691413211052499","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-5006-1"},{"key":"bibr5-09691413211052499","unstructured":"Terviseuuringute ja tervisestatistika andmebaas. VSR12: emakakaelav\u00e4hi s\u00f5eluuringu sihtr\u00fchma h\u00f5lmatus PAP-testi uuringuga vanuse j\u00e4rgi. Available at: https:\/\/statistika.tai.ee\/pxweb\/et\/Andmebaas\/Andmebaas__02Haigestumus__07Soeluuringud\/VSR12.px\/. (Accessed February 14, 2021)."},{"key":"bibr6-09691413211052499","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2018-001351"},{"key":"bibr7-09691413211052499","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4823"},{"key":"bibr8-09691413211052499","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2018.00077"},{"key":"bibr9-09691413211052499","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0000000000000476"},{"key":"bibr10-09691413211052499","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17176245"},{"key":"bibr11-09691413211052499","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2015.5348"},{"key":"bibr12-09691413211052499","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-003743"},{"key":"bibr13-09691413211052499","first-page":"1","volume":"15","author":"Lai T","year":"2013","journal-title":"Health Syst Transit"},{"key":"bibr14-09691413211052499","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1804-x"},{"key":"bibr15-09691413211052499","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151978"},{"key":"bibr16-09691413211052499","unstructured":"Statistical regions in the European Union and partner countries. NUTS And statistical regions. Eurostat 2021. Available at: https:\/\/ec.europa.eu\/eurostat\/documents\/3859598\/10967554\/KS-GQ-20-092-EN-N.pdf\/9d57ae79-3ee7-3c14-da3e-34726da385cf. (Accessed July 2, 2021)."},{"key":"bibr17-09691413211052499","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-11-0307"},{"key":"bibr18-09691413211052499","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2016.06.016"},{"key":"bibr19-09691413211052499","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2246-9"},{"key":"bibr20-09691413211052499","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-20-1226"},{"key":"bibr21-09691413211052499","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-020-00280-0"},{"key":"bibr22-09691413211052499","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2005.14.721"},{"key":"bibr23-09691413211052499","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.11.022"},{"key":"bibr24-09691413211052499","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2019.105953"}],"container-title":["Journal of Medical Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09691413211052499","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09691413211052499","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09691413211052499","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:25:14Z","timestamp":1777677914000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09691413211052499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,25]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1177\/09691413211052499"],"URL":"https:\/\/doi.org\/10.1177\/09691413211052499","relation":{},"ISSN":["0969-1413","1475-5793"],"issn-type":[{"value":"0969-1413","type":"print"},{"value":"1475-5793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,25]]}}}